--
--(--)
--
--(--)
Expected P&L on Expiry
Key Stats
0.00DAY`S RANGE0.00
0.00
0.00
--
--
--
--
--
--
--
Pricing Model
--
--
--
--
--
--
About ZNTL20260717C2.5
Biological Technology
Zentalis Pharmaceuticals, Inc., was incorporated in Delaware on December 23, 2014 as Zeno Pharmaceuticals, Inc. Zentalis Pharmaceuticals, Inc., is a clinical-stage pharmaceutical company dedicated to the discovery and development of clinically differentiated novel small molecule therapies targeting the underlying biological pathways of cancer.
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
